Drug Markets/Filgrastim

Filgrastim

4 NDCs across 1 manufacturer|0 Generic,4 Brand

Filgrastim is used to treat chemotherapy-induced febrile neutropenia and neutropenia, per the National Library of Medicine's MED-RT classification.

▸ More about this market

In 2024, Medicare Part D spent $7 million on Filgrastim across 2,908 claims for 1,038 beneficiaries.

Filgrastim is available as 4 NDCs from 1 manufacturer (0 generic, 4 brand), with NADAC prices from $304.09 to $650.05 per ML — the most expensive product costs about 2.1× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

4

0G / 4B

Manufacturers

1

competing in market

Price Spread

$304.09 – $650.05

per ML

7d Activity

4 flat

avg +0.0% WoW · of 4 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing FILGRASTIM

Drug Portfolio

4 NDCs total, 4 shown

Frequently Asked Questions

What is Filgrastim used to treat?

Filgrastim is used to treat chemotherapy-induced febrile neutropenia and neutropenia, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Filgrastim?

In 2024, Medicare Part D spent $7 million on Filgrastim across 2,908 claims for 1,038 beneficiaries.

How many Filgrastim products are on the market?

The Filgrastim drug market contains 4 NDCs from 1 manufacturer — 0 generic and 4 brand products.

What is the price range for Filgrastim?

NADAC reference prices for Filgrastim range from $304.0908 to $650.0520 per ML — the most expensive product costs about 2.1× the cheapest.

Which manufacturers make Filgrastim?

1 manufacturer lists Filgrastim in NADAC. Ranked by number of NDCs, the largest are Amgen Inc. (4).